107 related articles for article (PubMed ID: 25155377)
1. Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas.
Liszka Ł; Pająk J; Gołka D
Pathol Res Pract; 2014 Dec; 210(12):901-8. PubMed ID: 25155377
[TBL] [Abstract][Full Text] [Related]
2. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
Chang BD; Cao LS; Zhou HL
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
[TBL] [Abstract][Full Text] [Related]
3. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
4. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.
Edeline J; Mottier S; Vigneau C; Jouan F; Perrin C; Zerrouki S; Fergelot P; Patard JJ; Rioux-Leclercq N
Hum Pathol; 2012 Nov; 43(11):1982-90. PubMed ID: 22626276
[TBL] [Abstract][Full Text] [Related]
5. Microvascular network in renal carcinomas. Quantitative and tissue microarray immunohistochemical study.
Okoń K; Kawa R
Pol J Pathol; 2008; 59(2):107-15. PubMed ID: 18669177
[TBL] [Abstract][Full Text] [Related]
6. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.
Bierer S; Herrmann E; Köpke T; Neumann J; Eltze E; Hertle L; Wülfing C
Oncol Rep; 2008 Oct; 20(4):721-5. PubMed ID: 18813809
[TBL] [Abstract][Full Text] [Related]
7. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C
Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth inhibitor 174 is a negative regulator of aggressiveness and microvascular density in human clear cell renal cell carcinoma.
Wu L; Li X; Ye L; Shayiremu D; Deng X; Zhang X; Jiang W; Yang Y; Gong K; Zhang N
Anticancer Res; 2014 Feb; 34(2):715-22. PubMed ID: 24511004
[TBL] [Abstract][Full Text] [Related]
9. Relationship between tumour angiogenesis and expression of cyclo-oxygenase-2 and vascular endothelial growth factor-A in human renal cell carcinoma.
Yang S; Gao Q; Jiang W
J Int Med Res; 2015 Feb; 43(1):110-7. PubMed ID: 25488950
[TBL] [Abstract][Full Text] [Related]
10. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma.
Cao Y; Zhang ZL; Zhou M; Elson P; Rini B; Aydin H; Feenstra K; Tan MH; Berghuis B; Tabbey R; Resau JH; Zhou FJ; Teh BT; Qian CN
Cancer; 2013 Jan; 119(2):313-24. PubMed ID: 22811049
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.
Wan L; Huang J; Chen J; Wang R; Dong C; Lu S; Wu X
J BUON; 2015; 20(1):188-95. PubMed ID: 25778315
[TBL] [Abstract][Full Text] [Related]
12. Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.
Qi L; Du J; Zhang Z; Diao L; Chen X; Yao X
BJU Int; 2013 Aug; 112(4):E415-23. PubMed ID: 23879920
[TBL] [Abstract][Full Text] [Related]
13. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications.
Yao X; Qian CN; Zhang ZF; Tan MH; Kort EJ; Yang XJ; Resau JH; Teh BT
Clin Cancer Res; 2007 Jan; 13(1):161-9. PubMed ID: 17200351
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical and ultrastructural study of pancreatic microcystic serous cyst adenoma with special reference to tumor-associated microvasculature and vascular endothelial growth factor in tumor cells.
Yamazaki K; Eyden B
Ultrastruct Pathol; 2006; 30(1):119-28. PubMed ID: 16517478
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Tickoo SK; Alden D; Olgac S; Fine SW; Russo P; Kondagunta GV; Motzer RJ; Reuter VE
J Urol; 2007 Apr; 177(4):1258-63. PubMed ID: 17382701
[TBL] [Abstract][Full Text] [Related]
16. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
[TBL] [Abstract][Full Text] [Related]
17. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
[TBL] [Abstract][Full Text] [Related]
18. [Detection and clinical significance of platelet derived growth factor-BB and microvessel density in clear cell renal cell carcinoma].
Qi LF; Sun D; Zheng JH; Du J; Yao X
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):672-7. PubMed ID: 24332054
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
[TBL] [Abstract][Full Text] [Related]
20. Complexity of tumor vasculature in clear cell renal cell carcinoma.
Qian CN; Huang D; Wondergem B; Teh BT
Cancer; 2009 May; 115(10 Suppl):2282-9. PubMed ID: 19402071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
